New Approaches in Bispecific Antibody Development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

An emerging class of next-generation antibodies, bispecific antibodies (bsAb) can create a wide range of applications to meet the current unmet needs of patients. In this webinar, we will introduce S-DUAL bispecific antibody platform that enables high purity, thermostability, and manufacturability by eliminating mispairing risks, while maintaining high-quality structure for your novel finding.

Speaker:

Jina Kim
Senior Scientist of Bio R&D Center – Samsung Biologics


Register Now!

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters